1887

oa South African Medical Journal - Possibilities of modern oral diabetes therapy

 

Abstract

The new sulphonylurea substance glibenclamide (HB 419) exhibits differences in its mode of action and its clinical effect in comparison with the conventional sulphonylureas.

Loading

Article metrics loading...

/content/m_samj/45/4/AJA20785135_33705
1971-01-01
2016-12-03
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error